In most contemporary practice, serum VEGF‐D measurement is recommended as the initial non‐invasive diagnostic test, with levels ≥ 800 pg/mL considered virtually diagnostic of LAM [1]. Here, VEGFD is linked to lymphangioleiomyomatosis.